![Antiviral Drugs in Wastewater and Surface Waters: A New Pharmaceutical Class of Environmental Relevance? | Environmental Science & Technology Antiviral Drugs in Wastewater and Surface Waters: A New Pharmaceutical Class of Environmental Relevance? | Environmental Science & Technology](https://pubs.acs.org/cms/10.1021/es903216p/asset/images/large/es-2009-03216p_0004.jpeg)
Antiviral Drugs in Wastewater and Surface Waters: A New Pharmaceutical Class of Environmental Relevance? | Environmental Science & Technology
![Molecules | Free Full-Text | 11B NMR of the Morphological Evolution of Traditional Chinese Medicine Borax Molecules | Free Full-Text | 11B NMR of the Morphological Evolution of Traditional Chinese Medicine Borax](https://www.mdpi.com/molecules/molecules-29-00251/article_deploy/html/images/molecules-29-00251-g001.png)
Molecules | Free Full-Text | 11B NMR of the Morphological Evolution of Traditional Chinese Medicine Borax
![Biotransformation of the Antiviral Drugs Acyclovir and Penciclovir in Activated Sludge Treatment | Environmental Science & Technology Biotransformation of the Antiviral Drugs Acyclovir and Penciclovir in Activated Sludge Treatment | Environmental Science & Technology](https://pubs.acs.org/cms/10.1021/es103732y/asset/images/large/es-2010-03732y_0007.jpeg)
Biotransformation of the Antiviral Drugs Acyclovir and Penciclovir in Activated Sludge Treatment | Environmental Science & Technology
![Discovery of the Potent and Selective MC4R Antagonist PF-07258669 for the Potential Treatment of Appetite Loss | Journal of Medicinal Chemistry Discovery of the Potent and Selective MC4R Antagonist PF-07258669 for the Potential Treatment of Appetite Loss | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.2c02012/asset/images/medium/jm2c02012_0019.gif)
Discovery of the Potent and Selective MC4R Antagonist PF-07258669 for the Potential Treatment of Appetite Loss | Journal of Medicinal Chemistry
![Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug ... Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug ...](https://pubs.acs.org/cms/10.1021/acs.jmedchem.7b00231/asset/images/medium/jm-2017-002314_0026.gif)
Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug ...
Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor | Journal of Medicinal Chemistry
![Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based ... Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based ...](https://pubs.acs.org/cms/10.1021/acs.jmedchem.7b00231/asset/images/medium/jm-2017-002314_0018.gif)
Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based ...
![Metabolism-Directed Design of Oxetane-Containing Arylsulfonamide Derivatives as γ-Secretase Inhibitors | Journal of Medicinal Chemistry Metabolism-Directed Design of Oxetane-Containing Arylsulfonamide Derivatives as γ-Secretase Inhibitors | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm200893p/asset/images/large/jm-2011-00893p_0011.jpeg)
Metabolism-Directed Design of Oxetane-Containing Arylsulfonamide Derivatives as γ-Secretase Inhibitors | Journal of Medicinal Chemistry
Hospital Wastewater Treatment by Membrane Bioreactor: Performance and Efficiency for Organic Micropollutant Elimination | Environmental Science & Technology
![Metabolism-Directed Design of Oxetane-Containing Arylsulfonamide Derivatives as γ-Secretase Inhibitors | Journal of Medicinal Chemistry Metabolism-Directed Design of Oxetane-Containing Arylsulfonamide Derivatives as γ-Secretase Inhibitors | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm200893p/asset/images/medium/jm-2011-00893p_0006.gif)
Metabolism-Directed Design of Oxetane-Containing Arylsulfonamide Derivatives as γ-Secretase Inhibitors | Journal of Medicinal Chemistry
![Tengelykapcsolók kardáncsuklók bordástengelyek - Tengelykapcsolók - Körmös tengelykapcsolók - Öntöttvas körmös tengelykapcsoló - Power Belt Tengelykapcsolók kardáncsuklók bordástengelyek - Tengelykapcsolók - Körmös tengelykapcsolók - Öntöttvas körmös tengelykapcsoló - Power Belt](https://www.powerbelt.hu/uploads/productcategories/tgk_oldham_group_2.jpg)
Tengelykapcsolók kardáncsuklók bordástengelyek - Tengelykapcsolók - Körmös tengelykapcsolók - Öntöttvas körmös tengelykapcsoló - Power Belt
![Discovery of the Potent and Selective MC4R Antagonist PF-07258669 for the Potential Treatment of Appetite Loss | Journal of Medicinal Chemistry Discovery of the Potent and Selective MC4R Antagonist PF-07258669 for the Potential Treatment of Appetite Loss | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.2c02012/asset/images/medium/jm2c02012_0005.gif)